Wolverine Trading, LLC Fsd Pharma Inc. Call Options Transaction History

Wolverine Trading, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	BUY	$0.77 - $1.81 $2,541 - $5,973	3,300 Added 33.0%	13,300 $21,000
Q4 2022 Feb 14, 2023	BUY	$0.73 - $58.49 $7,300 - $584,900	10,000 New	10,000 $8,000
Q2 2022 Aug 15, 2022	SELL	$0.78 - $1.1 $4,836 - $6,820	-6,200 Reduced 27.56%	16,300 $13,000
Q1 2022 May 16, 2022	SELL	$0.82 - $1.1 $1,558 - $2,090	-1,900 Reduced 7.79%	22,500 $20,000
Q4 2021 Feb 14, 2022	SELL	$0.96 - $1.63 $864 - $1,467	-900 Reduced 3.56%	24,400 $25,000
Q3 2021 Nov 12, 2021	SELL	$1.45 - $1.84 $28,565 - $36,248	-19,700 Reduced 43.78%	25,300 $39,000
Q2 2021 Aug 06, 2021	BUY	$1.56 - $2.13 $70,200 - $95,850	45,000 New	45,000 $79,000
Q1 2021 May 14, 2021	SELL	$1.65 - $3.87 $41,580 - $97,524	-25,200 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$1.36 - $2.7 $34,272 - $68,040	25,200 New	25,200 $40,000

Ticker HUGE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 38,218,100
Market Cap $152M
Description
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.